• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TDP-43 作为额颞叶变性的一种可能的生物标志物:对现有抗体的系统评价。

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies.

出版信息

Acta Neuropathol Commun. 2015 Apr 1;3:15. doi: 10.1186/s40478-015-0195-1.

DOI:10.1186/s40478-015-0195-1
PMID:25853864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4380254/
Abstract

Frontotemporal lobar degeneration (FTLD) is one of the leading causes of dementia after Alzheimer's disease. A high-ranking candidate to become a diagnostic marker for a major pathological subtype of FTLD is the transactive response DNA binding protein of 43 kDa (TDP-43). The main objective is to elucidate which antibodies are specific for pathological TDP-43, with special interest in its modified isoforms. Indeed, TDP-43 has been shown to be hyperphosphorylated and truncated in disease. A secondary objective is to review existing immunoassays that quantify TDP-43 in biofluids. A systematic review of literature was performed by searching PubMed and Web of Science using predefined keywords. Of considered research papers the methods section was reviewed to select publications that enabled us to answer our learning objective. After quality assessment, antibody characteristics and related outcomes were extracted. We identified a series of well-characterized antibodies based on a scoring system that assessed the ability of each antibody to detect TDP-43 pathology. A selection of 29 unique antibodies was made comprising 10 high-ranking antibodies which were reported multiple times to detect TDP-43 pathology in both immunostaining and immunoblotting experiments and 19 additional antibodies which detected TDP-43 pathology but were only scored once. This systematic review provides an overview of antibodies that are reported to detect pathological TDP-43. These antibodies can be used in future studies of TDP-43 proteinopathies. Additionally, selected antibodies hold the potential to be used in the development of novel immunoassays for the quantification of TDP-43 in biofluids, as a possible biomarker for FTLD-TDP.

摘要

额颞叶痴呆(FTLD)是继阿尔茨海默病之后导致痴呆的主要原因之一。转激活反应 DNA 结合蛋白 43kDa(TDP-43)是 FTLD 主要病理亚型的一种有前途的诊断标志物候选物。主要目标是阐明哪些抗体是针对病理性 TDP-43 的特异性抗体,特别关注其修饰异构体。事实上,TDP-43 在疾病中已被证明发生过度磷酸化和截断。次要目标是综述现有的用于定量生物体液中 TDP-43 的免疫测定法。通过使用预定义的关键字在 PubMed 和 Web of Science 上进行文献系统综述。在考虑的研究论文中,对方法部分进行了审查,以选择能够回答我们学习目标的出版物。经过质量评估,提取了抗体特性和相关结果。我们根据评估每个抗体检测 TDP-43 病理学能力的评分系统,确定了一系列经过良好特征描述的抗体。选择了 29 种独特的抗体,其中包括 10 种高排名抗体,这些抗体在免疫染色和免疫印迹实验中多次报道可检测 TDP-43 病理学,以及 19 种额外的抗体可检测 TDP-43 病理学,但仅评分一次。本系统综述提供了已报道可检测病理性 TDP-43 的抗体概述。这些抗体可用于未来 TDP-43 蛋白病的研究。此外,选定的抗体有可能被用于开发新型免疫测定法,以定量生物体液中的 TDP-43,作为 FTLD-TDP 的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/4380254/ad359e1d89b2/40478_2015_195_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/4380254/ad359e1d89b2/40478_2015_195_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e6b/4380254/ad359e1d89b2/40478_2015_195_Fig1_HTML.jpg

相似文献

1
TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies.TDP-43 作为额颞叶变性的一种可能的生物标志物:对现有抗体的系统评价。
Acta Neuropathol Commun. 2015 Apr 1;3:15. doi: 10.1186/s40478-015-0195-1.
2
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
3
Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypes.对患有TDP-43病理学的额颞叶痴呆(FTLD)患者进行甲基化组分析,确定了特定于病理亚型的表观遗传特征。
Mol Neurodegener. 2025 Jul 6;20(1):80. doi: 10.1186/s13024-025-00869-2.
4
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
5
LATE-NC Stage 3: a diagnostic rubric to differentiate severe LATE-NC from FTLD-TDP.晚期神经认知障碍3期:一种区分重度晚期神经认知障碍与额颞叶痴呆-4型的诊断标准。
Acta Neuropathol. 2025 Apr 28;149(1):38. doi: 10.1007/s00401-025-02876-5.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
TDP-43 Epigenetic Facets and Their Neurodegenerative Implications.TDP-43 的表观遗传学特征及其神经退行性变的影响。
Int J Mol Sci. 2023 Sep 7;24(18):13807. doi: 10.3390/ijms241813807.
2
Plasma TDP-43 levels are associated with neuroimaging measures of brain structure in limbic regions.血浆TDP-43水平与边缘系统区域脑结构的神经影像学测量指标相关。
Alzheimers Dement (Amst). 2023 May 31;15(2):e12437. doi: 10.1002/dad2.12437. eCollection 2023 Apr-Jun.
3
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia.

本文引用的文献

1
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.额颞叶变性:通过个性化医疗定义表型多样性。
Acta Neuropathol. 2015 Apr;129(4):469-91. doi: 10.1007/s00401-014-1380-1. Epub 2014 Dec 31.
2
Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury.在神经毒性条件和创伤性脑损伤后,TDP-43对钙蛋白酶和半胱天冬酶-3蛋白水解的双重易损性。
J Cereb Blood Flow Metab. 2014 Sep;34(9):1444-52. doi: 10.1038/jcbfm.2014.105. Epub 2014 Jun 11.
3
Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases.
酪蛋白激酶 2 介导 HIV 和阿片类药物诱导的基底神经节中 TAR DNA 结合蛋白 43 的病理性磷酸化。
ASN Neuro. 2023 Jan-Dec;15:17590914231158218. doi: 10.1177/17590914231158218.
4
Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke.雷帕霉素对缺血性脑卒中 TDP-43 相关发病机制的治疗作用。
Int J Mol Sci. 2022 Dec 30;24(1):676. doi: 10.3390/ijms24010676.
5
LATE-NC staging in routine neuropathologic diagnosis: an update.常规神经病理诊断中的晚期神经节细胞(stage)分期:更新。
Acta Neuropathol. 2023 Feb;145(2):159-173. doi: 10.1007/s00401-022-02524-2. Epub 2022 Dec 13.
6
Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers.边缘系统为主型年龄相关性 TDP-43 脑病:临床病理特征和生物标志物的最新突破。
Curr Neurol Neurosci Rep. 2022 Nov;22(11):689-698. doi: 10.1007/s11910-022-01232-4. Epub 2022 Oct 3.
7
Metal content and kinetic properties of yeast RNA lariat debranching enzyme Dbr1.酵母 RNA 套索分支酶 Dbr1 的金属含量和动力学特性。
RNA. 2022 Jul;28(7):927-936. doi: 10.1261/rna.079159.122. Epub 2022 Apr 22.
8
Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD balance as a therapeutic strategy.线粒体功能失调在 ALS 运动皮层中伴随着 TDP-43 病理学而早期发生,并提示维持 NAD 平衡作为一种治疗策略。
Sci Rep. 2022 Mar 11;12(1):4287. doi: 10.1038/s41598-022-08068-5.
9
Selection and Modelling of a New Single-Domain Intrabody Against TDP-43.一种新型抗TDP-43单结构域胞内抗体的筛选与建模
Front Mol Biosci. 2022 Feb 14;8:773234. doi: 10.3389/fmolb.2021.773234. eCollection 2021.
10
A Microplate-Based Approach to Map Interactions between TDP-43 and α-Synuclein.一种基于微孔板的方法来绘制TDP - 43与α - 突触核蛋白之间的相互作用。
J Clin Med. 2022 Jan 24;11(3):573. doi: 10.3390/jcm11030573.
游离TDP-43作为神经退行性疾病诊断工具的作用有限。
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):351-6. doi: 10.3109/21678421.2014.905606. Epub 2014 May 16.
4
Progranulin protein levels are differently regulated in plasma and CSF.原颗粒蛋白在血浆和脑脊液中的水平受到不同的调节。
Neurology. 2014 May 27;82(21):1871-8. doi: 10.1212/WNL.0000000000000445. Epub 2014 Apr 25.
5
Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins.新型单克隆抗体针对正常和病理改变的人 TDP-43 蛋白。
Acta Neuropathol Commun. 2014 Mar 31;2:33. doi: 10.1186/2051-5960-2-33.
6
Dementia in 2013: frontotemporal lobar degeneration-building on breakthroughs.2013年的痴呆症:额颞叶变性——基于突破之上
Nat Rev Neurol. 2014 Feb;10(2):70-2. doi: 10.1038/nrneurol.2013.270. Epub 2014 Jan 7.
7
Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.携带 C9orf72 重复扩增或 GRN 突变的额颞叶痴呆患者血浆中磷酸化 TDP-43 水平升高。
J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):684-91. doi: 10.1136/jnnp-2013-305972. Epub 2013 Dec 4.
8
Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.通过定量测定脑脊液中的TDP-43对肌萎缩侧索硬化症与吉兰-巴雷综合征进行鉴别诊断。
Int J Neurosci. 2014 May;124(5):344-9. doi: 10.3109/00207454.2013.848440. Epub 2013 Oct 31.
9
Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.ALS 和 FTD 的汇聚机制:RNA 和蛋白质稳态的破坏。
Neuron. 2013 Aug 7;79(3):416-38. doi: 10.1016/j.neuron.2013.07.033.
10
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.TDP-43 驱动的 FTLD-ALS 谱障碍神经退行性变的病理机制。
Hum Mol Genet. 2013 Oct 15;22(R1):R77-87. doi: 10.1093/hmg/ddt349. Epub 2013 Jul 29.